Evidence map›Paper›PMID 41877511›Full record

ArticleChembiochem : a European journal of chemical biology2026

Generating Ultra-Fast Protein trans-Splicing of a Cysteine-Less and Semisynthetic Split Intein for Chemical Protein Labeling.

Christoph Humberg, Tobias M E Terhorst, Tim Pasch, Henning D Mootz

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christoph HumbergDepartment of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0003-3394-9338
Tobias M E TerhorstDepartment of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Münster, Germany.
Tim PaschDepartment of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-8528-983X
Henning D MootzDepartment of Chemistry and Pharmacy, Institute of Biochemistry, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-3385-0234

Funding

Deutsche Forschungsgemeinschaft (DFG) Grant MO1073/9-1
6 · The paper itself

Abstract

Cysteine-less split inteins have recently emerged as valuable addition to the protein labeling and modification toolbox as they can perform the protein trans-splicing (PTS) reaction under oxidizing conditions. Furthermore, their use is compatible with the chemical labeling and different redox states of cysteines in the extein sequences and hence the protein of interest. However, a rapidly splicing cysteine-less split intein with one short precursor fragment easily amenable to solid-phase peptide synthesis was still missing. A chemically synthesized split intein precursor allows for semisynthetic PTS, attractive to introduce fully synthetic sequence segments into the protein of interest. Here, we generate an optimized variant of the highly efficient split CL (cysteine-less) intein that splices with an ultra-fast rate on the second scale, comparable to the best performing split inteins. We achieved the nine- to 16-fold increase of the reaction rate by optimizing the artificial split site and the immediately flanking extein residues. Following chemical synthesis of the N-terminal precursor with an intein fragment of only 26 amino acids, we demonstrated protein semisynthesis by transferring a short fluorescently labeled peptide tag to a protein's N terminus with ultra-fast kinetics. The optimized split CL intein will thus further expand chemical protein labeling approaches.

Indexed as

CysteineInteinsProteinsProtein SplicingAmino Acid SequenceProtein EngineeringTrans-SplicingCysteineProteinsclick biologyposttranslational modificationprotein engineeringprotein ligationprotein semisynthesis

Identifiers

PMID41877511
PMCPMC13014065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.